by Richard Daverman, PhD
August 16, 2012 -- Two China medical research organizations will work with the National University of Ireland Galway to develop new biomaterials. Initially, the focus of the research will be polymers that preferentially deliver chemotherapies to tumors. Earlier this week, a memorandum of understanding was signed between Irish/NUI Galway officials and their counterparts from the Tianjin International Academy of Biotechnology and Medicine (TJAB), and China Nucleon Medical Technology Group, a CRO that provides medical imaging for clinical trials in China. More details....
